Literature DB >> 6126514

An assay for beta-adrenergic receptors in isolated human fat cells.

P Engfeldt, P Arner, H Wahrenberg, J Ostman.   

Abstract

The beta-adrenergic receptors have been characterized in isolated human adipocytes using a potent beta-adrenergic antagonist (-)-[3H]dihydroalprenolol. Binding of (-)-[3H]dihydroalprenolol to isolated fat cells was stereospecific and saturable, the maximum number of binding sites calculated being 7.8 +/- 2.2 pmol of bound ligand/10(7) cells, corresponding to 450,000 binding sites/cell. The dissociation constant was estimated to be 2.7 +/- 1.1 nM. The results with competition-inhibition experiments using beta-adrenergic agonists and antagonists indicated that the binding sites in isolated adipocytes were predominantly of the beta1-subtype; about 80% of the receptors were of this type. With the present method, specific beta-adrenergic receptor number and affinity in isolated human adipocytes could be determined in about 1 g of human adipose tissue.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6126514

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  4 in total

1.  Functional evidence that alpha 2A-adrenoceptors are responsible for antilipolysis in human abdominal fat cells.

Authors:  G Tarkovács; C Blandizzi; E S Vizi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

2.  Changes in catecholamine-induced lipolysis in isolated human fat cells during the first year of life.

Authors:  C Marcus; B Karpe; P Bolme; T Sonnenfeld; P Arner
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

3.  Beta-adrenoceptor expression in human fat cells from different regions.

Authors:  P Arner; L Hellström; H Wahrenberg; M Brönnegård
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  The lipolytic effect of beta 1- and beta 2-adrenoceptor activation in healthy human volunteers.

Authors:  C A Haffner; M J Kendall; S Maxwell; B Hughes
Journal:  Br J Clin Pharmacol       Date:  1993-01       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.